At Agilent Technologies, I reduced global supply chain inventory by $80M and 15 days from COVID-related highs while revenue declined. I managed approximately $900M in inventory and directed financial planning for $50M–$60M in annual capital expenditures.
At Hologic, I established the company’s first Global Supply Chain Strategic Plan and led a 17-person finance organization. Earlier, at Johnson & Johnson Worldwide Headquarters, I supported more than 40 acquisition, divestiture, and licensing transactions representing approximately $3B in transaction value.

